Do we need clinical trials to test the ability of transdermal HRT to prevent coronary heart disease?

Current Controlled Trials in Cardiovascular Medicine

Volumn 2, Issue 5, 2001, Pages 211-214

  Crook, D ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; ESTROGEN; FIBRINOGEN; GESTAGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; BLOOD PRESSURE REGULATION; BLOOD VESSEL FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; FIBRINOLYSIS; GLUCOSE HOMEOSTASIS; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MORBIDITY; NONHUMAN; POSTMENOPAUSE; RABBIT; RISK ASSESSMENT; SKIN MANIFESTATION; TRANSDERMAL PATCH;

EID: 0034758930     PISSN: 14686708     EISSN: None     Source Type: Journal    
DOI: 10.1186/CVM-2-5-211     Document Type: Article

References (34)

1. Estrogen replacement therapy and coronary heart disease; a quantitative assessment of the epidemiologic evidence
2. Sex, plasma lipoproteins and atherosclerosis: Prevailing assumptions and outstanding questions
3. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiological evidence
4. The protective effects of estrogen on the cardiovascular system
5. New developments in topical estrogen therapy
6. Postmenopausal hormone replacement therapy and coronary heart disease: Clinical implications of recent randomized trial results
7. Is the liver a target organ for estrogen?
8. Transdermal hormone replacement therapy for secondary prevention of coronary artery disease in post-menopausal women
9. Hormone therapy to prevent disease and prolong life in postmenopausal women
10. Transdermal estrogens do not appear to modify the extent of lesional areas of aortic atherosclerosis in oophorectomized rabbits on a cholesterol-rich diet
11. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study
12. Effects of estrogens and progestogens on plasma lipids and lipoproteins
13. Biological effects of transdermal estradiol
14. The metabolic consequences of treating post-menopausal women with non-oral hormone replacement therapy
15. The influence of female sex steroids on glucose metabolism and insulin action
16. Female sex hormones and gonadal steroids
17. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women
18. Effect of estrogen replacement therapy on insulin sensitivity of glucose metabolism and pre-resistance and resistance vessel function in healthy post-menopausal women
19. Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: Comparison of a new kind of transdermal estradiol treatment with oral therapy with conjugated estrogens
20. Lipoproteins and the haemostatic system in atherothrombotic disorders
21. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women
22. Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy
23. Assessment of the risk for venous thromboembolism among users of hormone replacement therapy
24. Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women
25. Estradiol-17beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension
26. Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women
27. Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease
28. Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes
29. Oral ethinyl estradiol, but not transdermal 17beta-estradiol, increases plasma C-reactive protein levels in men
30. Vascular resistance of uterine arteries: Physiological effects of estradiol and progesterone
31. Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women
32. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms
33. Acute effect of oestrogen replacement therapy on treadmill performance in postmenopausal women with coronary artery disease
34. Oestrogen improves exercise-induced myocardial ischaemia in women